Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$597,304
-$78,834 QoQ
Shares Held
24,805
+3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,636
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $45,176,274 across 12 Drug Manufacturers - General names. PFE ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
66,702 | $16,784,891 | |
| 2 | JNJ |
Johnson & Johnson
|
36,605 | $9,296,571 | |
| 3 | LLY |
ELI LILLY & Co
|
7,302 | $8,758,238 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,249 | $4,657,996 | |
| 5 | AMGN |
Amgen Inc
|
6,203 | $2,246,230 | |
| 6 | AZN |
Astrazeneca PLC
|
3,462 | $656,464 | |
| 7 | NVO |
Novo Nordisk A S
|
12,559 | $602,078 | |
| 8 | PFE |
Pfizer Inc
This page
|
24,805 | $597,304 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $597,304 | 24,805 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $676,138 | 24,079 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $518,741 | 20,833 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,948,659 | 76,478 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,615,620 | 66,651 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,224,631 | 48,328 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,330,479 | 50,150 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $2,039,228 | 70,464 | Shares | Sole | 2025-04-22 | |
| 2024-06-30 | $1,820,714 | 65,072 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $1,784,158 | 64,294 | Shares | Sole | 2025-04-22 | |
| 2023-12-31 | $1,735,979 | 60,298 | Shares | Sole | 2025-04-22 | |
| 2023-09-30 | $1,103,201 | 33,259 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,099,593 | 29,978 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,134,240 | 27,800 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,769,317 | 34,530 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,506,306 | 34,422 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $2,014,150 | 38,416 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,849,690 | 35,729 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,959,574 | 33,185 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,165,829 | 27,106 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,216,505 | 31,065 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,336,923 | 36,901 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $875,857 | 23,794 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $988,880 | 26,945 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $667,996 | 20,428 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $515,482 | 15,793 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||